Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1939 Sep;18(5):521–526. doi: 10.1172/JCI101065

THE IN VITRO FORMATION OF AN OXIDIZING AGENT BY SURVIVING TISSUES AND SULFANILAMIDE

J S Harris 1,2
PMCID: PMC434897  PMID: 16694683

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Harris J. S., Michel H. O. THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY. J Clin Invest. 1939 Sep;18(5):507–519. doi: 10.1172/JCI101064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hartmann A. F., Perley A. M., Barnett H. L. A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL. J Clin Invest. 1938 Nov;17(6):699–710. doi: 10.1172/JCI100997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Shaffer P. A. THE MODE OF ACTION OF SULPHANILAMID. Science. 1939 Jun 16;89(2320):547–550. doi: 10.1126/science.89.2320.547. [DOI] [PubMed] [Google Scholar]
  4. Van Heyningen W. E. The inhibition of respiration by cyanide. Biochem J. 1935 Sep;29(9):2036–2039. doi: 10.1042/bj0292036. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES